- Home
- FRD vs TKNO Comparison
FRD vs TKNO Comparison
Compare FRD & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FRD | TKNO |
|---|---|---|
| Founded | 1965 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 134.3M | 138.1M |
| IPO Year | 1995 | 2021 |
Fundamental Metrics
Financial Performance| Metric | FRD | TKNO |
|---|---|---|
| Price | $20.33 | $3.60 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 21.8K | ★ 98.3K |
| Earning Date | 06-11-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.79% | N/A |
| EPS Growth | N/A | ★ 43.86 |
| EPS | ★ 1.46 | N/A |
| Revenue | ★ $121,157,278.00 | $40,520,000.00 |
| Revenue This Year | N/A | $8.27 |
| Revenue Next Year | N/A | $13.13 |
| P/E Ratio | $14.04 | ★ N/A |
| Revenue Growth | ★ 55.82 | 7.35 |
| 52 Week Low | $14.52 | $1.91 |
| 52 Week High | $24.37 | $7.48 |
Technical Indicators
Market Signals| Indicator | FRD | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 61.00 | 63.40 |
| Support Level | $18.15 | $2.55 |
| Resistance Level | $20.60 | $4.94 |
| Average True Range (ATR) | 0.76 | 0.25 |
| MACD | 0.10 | 0.05 |
| Stochastic Oscillator | 72.99 | 91.89 |
Price Performance
Historical ComparisonAbout FRD Friedman Industries Inc.
Friedman Industries Inc is engaged in the manufacturing and processing of steel products. The company's operating segments include flat-roll products and Tubular Products. It generates maximum revenue from the flat-roll products segment. The company's products and services include Temper Pass, Cut-To-Length, Whole Coils, Toll Processing, Electric Resistance Welded Pipe (ERW), New Mill Secondary, and Pipe Finishing Services.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.